http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007070490-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9df90d7822cc480ce12c480f4089e229
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C09K3-00
filingDate 2005-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f4525e13042a1b76d25c939c91b2aec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bad3a53677fc1b10cd7fc475e4cbf0c8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5ea0b38d1a2f1a3149ba8454ab3355a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73cd43bda5202e43327a461041c31ef9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e90c27f95c0e451865b7080612074f02
publicationDate 2007-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2007070490-A
titleOfInvention Phase transition functional material between sol-gel and method for controlling phase transition
abstract A sol of a fine region - Phase metastatic function material between the gel cross or zone Le fine regions - - sol can gel transition control is a control method of the phase transition between the gel other. In the above phase transition functional material, an asymmetric azobenzene derivative selected from the following compounds and salts thereof is used as an active ingredient. [R 1 is an alkyl group, a cycloalkyl group, an aryl group or an aralkyl group, R 2 and R 3 are a hydrogen atom or a hydrocarbon group, m is 0 or a natural number, n is a natural number of 2 or more, * is a carbon whose R is R or Optically active enantiomer corresponding to S-form, L-form or D-form] A sol-gel phase-transition functional material represented by: In the above method, light is applied to a gel or sol derived from a solution in which the derivative is dissolved in a solvent. [Selection figure] None
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011126806-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100918645-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014101473-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7820192-B2
priorityDate 2005-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2003238962-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005314261-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468126982
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2272
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226418779
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408299504
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297

Total number of triples: 31.